BPC-157 vs TB-500: Which Is Better for Recovery?
BPC-157 and TB-500 are the two most studied recovery peptides in the research community — and the question "which is better?" misses the more important point: they work differently, on different mechanisms, and are genuinely complementary rather than redundant. This comparison covers what each does, where each excels, and why they're so often used together.
| Aspect | BPC-157 | TB-500 |
|---|---|---|
| Origin | Derived from human gastric juice protein BPC | Synthetic fragment of Thymosin Beta-4 (endogenous protein) |
| Size | 15 amino acids | 17 amino acids (fragment of 43-AA protein) |
| Primary mechanism | NO system modulation, VEGF upregulation, fibroblast activation at injury site | Actin regulation, systemic angiogenesis, cell migration to injury |
| Distribution | Works primarily locally — concentrates at the injection site and injury | Distributes systemically — reaches injuries throughout the body from any injection site |
| Gut applications | Yes — oral BPC-157 for IBD, ulcers, leaky gut | No documented gut-specific use |
| Cardiac research | Some cardioprotective data in animal models | Stronger cardiac data — studied in porcine ischemic heart models |
| Neurological effects | Dopamine/serotonin stabilisation; some neuroprotective research | Remyelination research; nerve regeneration studies |
| Typical dose | 200–500 mcg per injection | 2–5 mg per injection (weekly or twice weekly) |
| Injection frequency | Once or twice daily | 1–2x per week (longer half-life) |
| Tumour growth concern | Theoretical only — no confirmed evidence | More frequently cited concern — TB-500's systemic distribution and pro-angiogenic effects raise slightly more caution |
The combination of BPC-157 and TB-500 — popularised as the "Wolverine Stack" and discussed on the Joe Rogan Experience — is mechanistically additive rather than redundant. The two compounds target different points in the healing cascade:
- BPC-157 works at the injury site — recruiting fibroblasts, reducing local inflammation, and stimulating local blood vessel formation
- TB-500 improves systemic blood flow — promoting the migration of repair cells (platelets, immune cells, fibroblasts) from circulation to the injury location
- Together, BPC-157 creates the repair environment locally while TB-500 sends the cellular resources systemically — a genuinely additive combination
- The Wolverine Stack (BPC-157 + TB-500) is the most widely discussed recovery protocol in the peptide research community and was discussed by Joe Rogan and Andrew Huberman on JRE episodes
- Typical stack: BPC-157 (250–500 mcg daily) + TB-500 (2–5 mg twice weekly), 8–12 week cycle
Research use only. Neither BPC-157 nor TB-500 is FDA-approved for human use. All comparison data is derived from animal studies. This article is for educational purposes only.
All BPC-157 Guides
Other Articles
Calculator
Calculate exact reconstitution volumes and insulin unit doses for any peptide protocol.
Open Calculator →
